These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The vitro efficacy of beta-lactam and beta-lactamase inhibitors against multidrug resistant clinical strains of Mycobacterium tuberculosis. Dinçer I, Ergin A, Kocagöz T. Int J Antimicrob Agents; 2004 Apr; 23(4):408-11. PubMed ID: 15081094 [Abstract] [Full Text] [Related]
23. Multidrug resistance in Gram-negative bacteria that produce extended-spectrum beta-lactamases (ESBLs). Giamarellou H. Clin Microbiol Infect; 2005 Jul; 11 Suppl 4():1-16. PubMed ID: 15953019 [Abstract] [Full Text] [Related]
24. An explicit model for bacterial resistance: application to beta-lactam antibiotics. Waley SG. Microbiol Sci; 1987 May; 4(5):143-6. PubMed ID: 3153188 [Abstract] [Full Text] [Related]
27. Beta-lactamases as the main resistance factor to penicillin-related antibiotics. Frère JM, Joris B. Ann Biol Clin (Paris); 1988 Jan; 46(2):151-6. PubMed ID: 3260085 [Abstract] [Full Text] [Related]
28. The incidence of beta-lactamase-producing pathogens. Acar JF, Kitzis MD, Gutmann L. APMIS Suppl; 1989 Jan; 5():2-8. PubMed ID: 2660867 [Abstract] [Full Text] [Related]
29. Hospital-acquired respiratory tract infections: clinical experience with beta-lactam/beta-lactamase inhibitors. Akova M. Int J Clin Pract Suppl; 2002 Mar; (125):19-27; discussion 37-9. PubMed ID: 12014853 [Abstract] [Full Text] [Related]
32. Beta-lactamases: a new twist to an old problem. Nichols WW. Microbiol Sci; 1987 May; 4(5):147-8. PubMed ID: 3153189 [Abstract] [Full Text] [Related]
33. [Detection of resistance phenotypes in gram-negative bacteria]. Navarro F, Calvo J, Cantón R, Fernández-Cuenca F, Mirelis B. Enferm Infecc Microbiol Clin; 2011 May; 29(7):524-34. PubMed ID: 21696863 [Abstract] [Full Text] [Related]
34. beta-Lactam resistance and beta-lactamases in bacteria of animal origin. Li XZ, Mehrotra M, Ghimire S, Adewoye L. Vet Microbiol; 2007 Apr 15; 121(3-4):197-214. PubMed ID: 17306475 [Abstract] [Full Text] [Related]
35. In vitro activities of ertapenem against drug-resistant Streptococcus pneumoniae and other respiratory pathogens from 12 Asian countries. Song JH, Ko KS, Lee MY, Park S, Baek JY, Lee JY, Heo ST, Kwon KT, Ryu SY, Oh WS, Peck KR, Lee NY. Diagn Microbiol Infect Dis; 2006 Dec 15; 56(4):445-50. PubMed ID: 16949783 [Abstract] [Full Text] [Related]
36. Beta-lactam antibiotic resistance: a current structural perspective. Wilke MS, Lovering AL, Strynadka NC. Curr Opin Microbiol; 2005 Oct 15; 8(5):525-33. PubMed ID: 16129657 [Abstract] [Full Text] [Related]
37. What's new in antibiotic resistance? Focus on beta-lactamases. Babic M, Hujer AM, Bonomo RA. Drug Resist Updat; 2006 Jun 15; 9(3):142-56. PubMed ID: 16899402 [Abstract] [Full Text] [Related]
38. Antimicrobial resistance with focus on beta-lactam resistance in gram-negative bacilli. Pitout JD, Sanders CC, Sanders WE. Am J Med; 1997 Jul 15; 103(1):51-9. PubMed ID: 9236486 [Abstract] [Full Text] [Related]
39. IRT and CMT beta-lactamases and inhibitor resistance. Cantón R, Morosini MI, de la Maza OM, de la Pedrosa EG. Clin Microbiol Infect; 2008 Jan 15; 14 Suppl 1():53-62. PubMed ID: 18154528 [Abstract] [Full Text] [Related]
40. Metallo-β-lactamases: a last frontier for β-lactams? Cornaglia G, Giamarellou H, Rossolini GM. Lancet Infect Dis; 2011 May 15; 11(5):381-93. PubMed ID: 21530894 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]